Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001104659-18-036483

Exec VP & CFO acquired 6,392 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Heberlig Chris · Exec VP & CFO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-05-29 Conversion : show line 1 in the form +6,392 42,991 D

Table II: Derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-02-09 Purchase : show line 2 in the form Series C Preferred Shares +6,392 $15.64 $99,995 6,392 D
2018-05-29 Conversion : show line 3 in the form Series A Preferred Shares −74,935 0 D
2018-05-29 Conversion : show line 4 in the form Series C Preferred Shares −6,392 0 D
2018-05-29 Conversion : show line 5 in the form Class B Common Shares +74,935 440,920 D
Loading xslF345X03/a4.xml…